Q3 2026 13F filing
Updated 6 days ago56 disclosed positions worth $672.2M
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | P PTC THERAPEUTICS INC | $56.7M | 875.3K | 8.44% | — |
| 2 | J IOVANCE BIOTHERAPEUTICS INC | $51.4M | 3.47M | 7.65% | — |
| 3 | I INSMED INC | $50.6M | 443.6K | 7.53% | — |
| 4 | A ACADIA PHARMACEUTICALS INC | $50.1M | 2.49M | 7.45% | — |
| 5 | B BIOMARIN PHARMACEUTICAL INC | $38.5M | 642.5K | 5.73% | — |
| 6 | M MIRUM PHARMACEUTICALS INC | $33.1M | 387.3K | 4.93% | — |
| 7 | U UNITED THERAPEUTICS CORP DEL | $31.9M | 58.9K | 4.75% | — |
| 8 | D DYNE THERAPEUTICS INC | $30.3M | 1.88M | 4.51% | — |
| 9 | B BIOGEN INC | $30M | 132.9K | 4.47% | — |
| 10 | A ANAPTYSBIO INC | $29.9M | 595.3K | 4.45% | — |
| 11 | C CAREDX INC | $27.6M | 424.6K | 4.11% | — |
| 12 | T FIRST TRACKS BIOTHERAPEUTICS | $26.3M | 741.1K | 3.91% | — |
| 13 | I DISC MEDICINE INC | $26M | 396.5K | 3.86% | — |
| 14 | N NOVOCURE LTD | $19.3M | 1.21M | 2.87% | — |
| 15 | B BICARA THERAPEUTICS INC | $12.8M | 689.3K | 1.91% | — |
| 16 | A ANNEXON INC | $11.9M | 2.81M | 1.77% | — |
| 17 | S SYNDAX PHARMACEUTICALS INC | $11.2M | 596.4K | 1.67% | — |
| 18 | C CELLDEX THERAPEUTICS INC NEW | $11.1M | 343.1K | 1.65% | — |
| 19 | R ULTRAGENYX PHARMACEUTICAL IN | $10.7M | 710.0K | 1.59% | — |
| 20 | P PROTHENA CORP PLC | $9.5M | 1.13M | 1.41% | — |
| 21 | T TRAVERE THERAPEUTICS INC | $9.4M | 158.9K | 1.39% | — |
| 22 | A ALKERMES PLC | $8.3M | 203.7K | 1.23% | — |
| 23 | ? N/A COMPASS THERAPEUTICS INC | $7.4M | 7.15M | 1.11% | — |
| 24 | M AGIOS PHARMACEUTICALS INC | $6.7M | 201.0K | 0.99% | — |
| 25 | T TAYSHA GENE THERAPIES INC | $6.5M | 1.34M | 0.97% | — |
| 26 | A ACLARIS THERAPEUTICS INC | $6.1M | 1.16M | 0.91% | — |
| 27 | C CAPRICOR THERAPEUTICS INC | $5.2M | 548.1K | 0.77% | — |
| 28 | A ALIGN TECHNOLOGY INC | $4.6M | 31.4K | 0.68% | — |
| 29 | N NEWAMSTERDAM PHARMA COMPANY | $4M | 162.9K | 0.59% | — |
| 30 | T PROTARA THERAPEUTICS INC | $3.2M | 1.04M | 0.47% | — |
| 31 | C CONTINEUM THERAPEUTICS INC | $3M | 220.2K | 0.44% | — |
| 32 | E EDWARDS LIFESCIENCES CORP | $2.9M | 33.6K | 0.43% | — |
| 33 | V VERASTEM INC | $2.6M | 325.5K | 0.39% | — |
| 34 | N NEUROCRINE BIOSCIENCES INC | $2.6M | 18.1K | 0.38% | — |
| 35 | S SAGIMET BIOSCIENCES INC | $2.5M | 250.0K | 0.37% | — |
| 36 | A ADLAI NORTYE GROUP LTD | $2.4M | 149.5K | 0.36% | — |
| 37 | S STOKE THERAPEUTICS INC | $2.2M | 84.6K | 0.33% | — |
| 38 | O ORUKA THERAPEUTICS INC | $2.1M | 25.6K | 0.32% | — |
| 39 | C CRISPR THERAPEUTICS AG | $2M | 36.9K | 0.30% | — |
| 40 | Q PYXIS ONCOLOGY INC | $2M | 864.3K | 0.30% | — |
| 41 | C CYTOKINETICS INC | $2M | 30.0K | 0.29% | — |
| 42 | B BIONTECH SE | $1.9M | 19.6K | 0.29% | — |
| 43 | N NUVATION BIO INC | $1.8M | 326.6K | 0.27% | — |
| 44 | X XENON PHARMACEUTICALS INC | $1.8M | 47.9K | 0.27% | — |
| 45 | H HUMANA INC | $1.5M | 4.0K | 0.23% | — |
| 46 | C COMPASS PATHWAYS PLC | $1.4M | 115.6K | 0.21% | — |
| 47 | E EHEALTH INC | $1M | 1.43M | 0.15% | — |
| 48 | X XERIS BIOPHARMA HOLDINGS INC | $998K | 104.4K | 0.15% | — |
| 49 | U UROGEN PHARMA LTD | $995K | 24.5K | 0.15% | — |
| 50 | M MADRIGAL PHARMACEUTICALS INC | $901K | 1.8K | 0.13% | — |